Edge Therapeutics Announces Appointment of Harry J. Sacks, M.D., FAAP, as Vice President, Clinical Development
06 juil. 2016 16h30 HE
|
Edge Therapeutics, Inc.
BERKELEY HEIGHTS, N.J., July 06, 2016 (GLOBE NEWSWIRE) -- Edge Therapeutics, Inc. (Nasdaq:EDGE), a clinical-stage biotechnology company developing novel hospital-based therapies in the management...
Edge Therapeutics to Present at Upcoming Investor Conferences
02 juin 2016 07h30 HE
|
PDS Biotechnology Corporation
BERKELEY HEIGHTS, N.J., June 02, 2016 (GLOBE NEWSWIRE) -- Edge Therapeutics, Inc. (Nasdaq:EDGE), a clinical-stage biotechnology company developing novel hospital-based therapies for the management...
Edge Therapeutics Receives FDA Fast Track Designation for EG-1962 for the Treatment of Subarachnoid Hemorrhage
13 mai 2016 07h30 HE
|
PDS Biotechnology Corporation
BERKELEY HEIGHTS, N.J., May 13, 2016 (GLOBE NEWSWIRE) -- Edge Therapeutics, Inc. (Nasdaq:EDGE), a clinical-stage biotechnology company developing novel hospital-based therapies for the management...
Edge Therapeutics Reports First Quarter 2016 Financial Results
03 mai 2016 07h00 HE
|
PDS Biotechnology Corporation
BERKELEY HEIGHTS, N.J. , May 03, 2016 (GLOBE NEWSWIRE) -- Edge Therapeutics, Inc. (Nasdaq:EDGE), a clinical stage biotechnology company developing novel hospital-based therapies in the management...
Edge Therapeutics to Host a Conference Call on May 3, 2016 to Discuss First Quarter 2016 Financial Results
26 avr. 2016 09h00 HE
|
PDS Biotechnology Corporation
BERKELEY HEIGHTS, N.J., April 26, 2016 (GLOBE NEWSWIRE) -- Edge Therapeutics, Inc. (Nasdaq:EDGE), a clinical stage biotechnology company developing novel hospital-based therapies in the management...
Edge Therapeutics to Present at the 15th Annual Needham Healthcare Conference
05 avr. 2016 09h00 HE
|
PDS Biotechnology Corporation
BERKELEY HEIGHTS, N.J., April 05, 2016 (GLOBE NEWSWIRE) -- Edge Therapeutics, Inc. (Nasdaq:EDGE), a clinical stage biotechnology company developing novel hospital-based therapies in the management...
Edge Therapeutics Reports Fourth Quarter and Full-Year 2015 Financial Results
08 mars 2016 07h00 HE
|
PDS Biotechnology Corporation
BERKELEY HEIGHTS, N.J., March 08, 2016 (GLOBE NEWSWIRE) -- Edge Therapeutics, Inc. (Nasdaq:EDGE), a clinical stage biotechnology company developing novel hospital-based therapies in the management...
Edge Therapeutics to Present at the Cowen and Company 36th Annual Health Care Conference
02 mars 2016 08h00 HE
|
PDS Biotechnology Corporation
BERKELEY HEIGHTS, N.J., March 02, 2016 (GLOBE NEWSWIRE) -- Edge Therapeutics, Inc. (Nasdaq:EDGE), a clinical stage biotechnology company developing novel hospital-based therapies in the management...
Edge Therapeutics to Host a Conference Call on March 8, 2016 to Discuss Fourth Quarter and Full-Year 2015 Financial Results
01 mars 2016 08h00 HE
|
PDS Biotechnology Corporation
BERKELEY HEIGHTS, N.J., March 01, 2016 (GLOBE NEWSWIRE) -- Edge Therapeutics, Inc. (Nasdaq:EDGE), a clinical stage biotechnology company developing novel hospital-based therapies in the...
Edge Therapeutics Announces New Data Highlighting the Potential Pharmacoeconomic Impact of EG-1962 in Aneurysmal Subarachnoid Hemorrhage
19 févr. 2016 10h00 HE
|
PDS Biotechnology Corporation
Reduced length of ICU stay by 3.5 days, hospital stay by 2.5 days versus standard of careBuilds on efficacy data from Phase 1/2 clinical study, where EG-1962 doubled chances of favorable clinical...